Medline (MDLN) Enterprise Value (2024 - 2026)

Medline (MDLN) has 3 years of Enterprise Value data on file, last reported at $5.8 billion in Q1 2026.

• On a quarterly basis, Enterprise Value changed N/A year-over-year to $5.8 billion in Q1 2026; TTM through Mar 2026 was $5.8 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $6.6 billion, up 3421.61% from the prior year.
• Enterprise Value for Q1 2026 stood at $5.8 billion, down from $6.6 billion in the prior quarter.
• Over the last five years, Enterprise Value for MDLN reached as high as $6.6 billion in Q4 2025 and fell as low as -$199.0 million in Q4 2024.
• Historically, Enterprise Value has averaged $4.1 billion across 3 years, with a median of $5.8 billion in 2026.
• On a YoY basis, Enterprise Value climbed as much as 3421.61% in 2025 and fell as far as 3421.61% in 2025.
• Year by year, Enterprise Value stood at -$199.0 million in 2024, then jumped by 3421.61% to $6.6 billion in 2025, then slipped by 11.63% to $5.8 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $5.8 billion in Q1 2026, $6.6 billion in Q4 2025, and -$199.0 million in Q4 2024.